DE2420706C3 - Verfahren zum Herstellen von spezifischen Antigenen aus Schistosomen und jene enthaltendes Mittel - Google Patents

Verfahren zum Herstellen von spezifischen Antigenen aus Schistosomen und jene enthaltendes Mittel

Info

Publication number
DE2420706C3
DE2420706C3 DE2420706A DE2420706A DE2420706C3 DE 2420706 C3 DE2420706 C3 DE 2420706C3 DE 2420706 A DE2420706 A DE 2420706A DE 2420706 A DE2420706 A DE 2420706A DE 2420706 C3 DE2420706 C3 DE 2420706C3
Authority
DE
Germany
Prior art keywords
schistosomes
solution
antigens
extraction
schistosomiasis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2420706A
Other languages
German (de)
English (en)
Other versions
DE2420706A1 (de
DE2420706B2 (de
Inventor
Burkhard Dr. 3550 Marburg Enders
Guenter 3570 Stadt Allendorf Henke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Priority to DE2420706A priority Critical patent/DE2420706C3/de
Priority to ES436866A priority patent/ES436866A1/es
Priority to IT22763/75A priority patent/IT1049537B/it
Priority to NL7504853A priority patent/NL7504853A/xx
Priority to GB1734675A priority patent/GB1478082A/en
Priority to EG247/75A priority patent/EG12734A/xx
Priority to AT325475A priority patent/AT344329B/de
Priority to CH540475A priority patent/CH617775A5/de
Priority to IE940/75A priority patent/IE41024B1/xx
Priority to JP50051942A priority patent/JPS50145518A/ja
Priority to CA225,850A priority patent/CA1052694A/en
Priority to LU72375A priority patent/LU72375A1/xx
Priority to DK184575A priority patent/DK140044C/da
Priority to ZA00752717A priority patent/ZA752717B/xx
Priority to BE155933A priority patent/BE828565A/xx
Priority to FR7513347A priority patent/FR2268532B1/fr
Publication of DE2420706A1 publication Critical patent/DE2420706A1/de
Priority to US05/840,175 priority patent/US4150107A/en
Publication of DE2420706B2 publication Critical patent/DE2420706B2/de
Application granted granted Critical
Publication of DE2420706C3 publication Critical patent/DE2420706C3/de
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0003—Invertebrate antigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE2420706A 1974-04-29 1974-04-29 Verfahren zum Herstellen von spezifischen Antigenen aus Schistosomen und jene enthaltendes Mittel Expired DE2420706C3 (de)

Priority Applications (17)

Application Number Priority Date Filing Date Title
DE2420706A DE2420706C3 (de) 1974-04-29 1974-04-29 Verfahren zum Herstellen von spezifischen Antigenen aus Schistosomen und jene enthaltendes Mittel
ES436866A ES436866A1 (es) 1974-04-29 1975-04-23 Procedimiento para la preparacion de antigenos.
IT22763/75A IT1049537B (it) 1974-04-29 1975-04-24 Processo per l ottenimento di antigeni da schistosomi mezzo contenente tali antigeni e suo impiego
NL7504853A NL7504853A (nl) 1974-04-29 1975-04-24 Werkwijze voor het winnen van antigenen uit schistosomem, dit soort antigenen houdende middelen en hun toepassing.
GB1734675A GB1478082A (en) 1974-04-29 1975-04-25 Process for obtaining antigens from schistosomes agent containing these antigens and its use
EG247/75A EG12734A (en) 1974-04-29 1975-04-26 Process for obtaining antigens from schistosomes agent containing these antigents and its use
ZA00752717A ZA752717B (en) 1974-04-29 1975-04-28 Process for obtaining antigens from schistosomes, agent containing these antigens and its use
IE940/75A IE41024B1 (en) 1974-04-29 1975-04-28 Process for obtaining antigens from schistosomes, agent containing these antigens and its use
AT325475A AT344329B (de) 1974-04-29 1975-04-28 Verfahren zur herstellung von antigenen
CA225,850A CA1052694A (en) 1974-04-29 1975-04-28 Process for obtaining antigens from schistosomes, agent containing these antigens and its use
LU72375A LU72375A1 (enExample) 1974-04-29 1975-04-28
DK184575A DK140044C (da) 1974-04-29 1975-04-28 Fremgangsmaade til udvinding af antigener fra schistosoma til diagnostisk brug
CH540475A CH617775A5 (en) 1974-04-29 1975-04-28 Process for the preparation of antigens from schistosomes
JP50051942A JPS50145518A (enExample) 1974-04-29 1975-04-28
BE155933A BE828565A (fr) 1974-04-29 1975-04-29 Procede de preparation d'antigenes a partir de schistosomes, agents contenant ces antigenes et leur utilisation
FR7513347A FR2268532B1 (enExample) 1974-04-29 1975-04-29
US05/840,175 US4150107A (en) 1974-04-29 1977-11-07 Antigen from schistosomes and process for obtaining same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2420706A DE2420706C3 (de) 1974-04-29 1974-04-29 Verfahren zum Herstellen von spezifischen Antigenen aus Schistosomen und jene enthaltendes Mittel

Publications (3)

Publication Number Publication Date
DE2420706A1 DE2420706A1 (de) 1975-10-30
DE2420706B2 DE2420706B2 (de) 1979-03-22
DE2420706C3 true DE2420706C3 (de) 1979-11-22

Family

ID=5914244

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2420706A Expired DE2420706C3 (de) 1974-04-29 1974-04-29 Verfahren zum Herstellen von spezifischen Antigenen aus Schistosomen und jene enthaltendes Mittel

Country Status (16)

Country Link
JP (1) JPS50145518A (enExample)
AT (1) AT344329B (enExample)
BE (1) BE828565A (enExample)
CA (1) CA1052694A (enExample)
CH (1) CH617775A5 (enExample)
DE (1) DE2420706C3 (enExample)
DK (1) DK140044C (enExample)
EG (1) EG12734A (enExample)
ES (1) ES436866A1 (enExample)
FR (1) FR2268532B1 (enExample)
GB (1) GB1478082A (enExample)
IE (1) IE41024B1 (enExample)
IT (1) IT1049537B (enExample)
LU (1) LU72375A1 (enExample)
NL (1) NL7504853A (enExample)
ZA (1) ZA752717B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2356428A1 (fr) * 1976-06-29 1978-01-27 Inserm Ctre Technologie Biomed Procede de preparation d'un agent immunologique antiparasitaire, produit obtenu et son application
FR2601037B1 (fr) * 1986-07-03 1988-10-21 Pasteur Institut Peptide presentant des proprietes antigeniques isole de la proteine 28 kd de s. mansoni et son procede d'isolement, anticorps monoclonaux reconnaissant au moins un epitope dudit peptide et application de celui-ci dans l'induction de la synthese d'anticorps neutralisants
KR20230092004A (ko) * 2020-10-27 2023-06-23 메르크 파텐트 게엠베하 쉬스토소마 감염의 검출을 위한 단백질

Also Published As

Publication number Publication date
DK184575A (da) 1975-10-30
FR2268532B1 (enExample) 1980-01-25
IE41024B1 (en) 1979-10-10
ZA752717B (en) 1976-03-31
DE2420706A1 (de) 1975-10-30
FR2268532A1 (enExample) 1975-11-21
DK140044B (da) 1979-06-11
ATA325475A (de) 1977-11-15
CA1052694A (en) 1979-04-17
JPS50145518A (enExample) 1975-11-21
NL7504853A (nl) 1975-10-31
IT1049537B (it) 1981-02-10
LU72375A1 (enExample) 1977-02-03
DK140044C (da) 1979-11-12
IE41024L (en) 1975-10-29
DE2420706B2 (de) 1979-03-22
AT344329B (de) 1978-07-10
BE828565A (fr) 1975-10-29
CH617775A5 (en) 1980-06-13
GB1478082A (en) 1977-06-29
EG12734A (en) 1979-06-30
ES436866A1 (es) 1977-01-01

Similar Documents

Publication Publication Date Title
Kaji et al. Isolation of Asian virus from extrapulmonary tissues in fatal human influenza.
EP0312108B1 (de) Mittel zur Kontrastierung von bösartigen Neubildungen bei ihrer Diagnostik
DE2745237A1 (de) Mittel zur immunisierung und zum nachweis von speziellen krebsarten
Mealey Turn-over of carrier-free zirconium-89 in man
DE2420706C3 (de) Verfahren zum Herstellen von spezifischen Antigenen aus Schistosomen und jene enthaltendes Mittel
DE69228061T2 (de) Sulfatierte glykolipide, die eine galaktose-3-0-sulfate-gruppierung enthalten, und spezifische fänger für diese für die verwendung in der prophylaxe oder therapie der prädiabetis, diabetis und/oder damit zusammenhängender komplikationen in einem individuum
DE2619715A1 (de) Tumor-antigen und verfahren zu dessen herstellung
DE2355094A1 (de) Tetanus-vaccine und verfahren zu deren herstellung
KAMINSKI et al. Human infection with Dermatophilus congolensis
CH404858A (de) Verfahren zur Herstellung von wachstumfördernde Stoffe enthaltenden Präparaten
Avode et al. Epilepsy, cysticercosis and and neurocysticercosis in Benin
DD145705A1 (de) Herstellungsverfahren von organspezifischen retrovirusimmunpraeparaten fuer prophylaxe,therapie und diagnostik
DE3510795C2 (de) Verfahren zur Herstellung eines mikrobiellen Extrakts, das bei dem Verfahren erhaltene Produkt und ein es enthaltendes Arzneimittel
US4150107A (en) Antigen from schistosomes and process for obtaining same
DE4419264A1 (de) Antigen, um Menschen und Tieren eine schützende Immunität gegen Wurminfektionen zu verleihen
Wilson Coccidioidomycosis as a tool in the study of granulomatous disease
DE2213709A1 (de) Verfahren zur Herstellung eines Interferonerzeugers
DE1945251A1 (de) Verfahren zur Beeinflussung der quantitativen Antikoerperbildung bei der aktiven Immunisierung und der Desensibilisierung
DE2728802C2 (de) Verfahren zum Herstellen eines antischistosomen immunologischen Mittels
DE2953223T1 (de) B-glucuronidase activity and/or ph-dependent pharmaceuticals and their methods of production and use for selective treatment of diseases
DE4204132C2 (de) Aufbereitung für die Gewinnung von Vakzinen für eine Immuntherapie
DE238162C (enExample)
DE3236298C2 (enExample)
AT398899B (de) Unter verwendung von eigenblut hergestellte aufbereitung für die diagnose und/oder gewinnung von vakzinen für eine immuntherapie
EP0251046B1 (de) Diagnostikum zur szintigraphischen Darstellung von bösartigen Tumoren

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
8339 Ceased/non-payment of the annual fee